Abbott stock rises after CEO Robert Ford buys $2 million in shares — what ABT investors watch next

Abbott Laboratories saw its shares climb roughly 1.3% on Monday, closing near $108.77 in after-hours trading. A recent filing revealed that Chairman and CEO Robert B. Ford acquired 18,800 shares at an average price of $107.1259.

27 January 2026

Abbott Laboratories stock drifts into earnings after Canada widens Libre 3 Plus coverage

Abbott Laboratories said its FreeStyle Libre 3 Plus glucose sensor is now publicly funded across every province in Canada. The stock ended down 0.2% at $125.92 on Friday.

10 January 2026

Earnings Reports·NASDAQ:ABT·Stock Market

Abbott Laboratories stock drifts into earnings after Canada widens Libre 3 Plus coverage

TechStock² Updates

Netflix Sets September 17 Return for Stranger Things: Tales From ’85, Eyes $3 Billion in Ad Revenue

Tesla Shares Drop 1.7% Amid $1.09 Trillion Market Cap and 1.4% Operating Margin

Micron Shares Edge Down 0.3% After $50 Billion Quarter Sets Higher Bar for September 30

Transocean Shares Gain 1.0% With $212 Million in Cash Flow Offset by $5.1 Billion Debt Burden

NuScale Power Drops 4.6% After Investors Weigh $4 Billion Valuation Against $75,000 Quarterly Revenue

Bank of America Shares Gain 1.9% as Rate Speculation Highlights $16 Billion Net Interest Income

Hyperliquid Strategies Stock Falls 9.5% as $2.4 Billion HYPE Treasury Tests Valuation

Moderna Shares Drop 3.4% with $55 Billion Valuation Raising Questions About Cancer Vaccine Progress

Ford Shares Edge Down 0.5% as $4 Billion EV Deficit Challenges $11 Billion Profit Target

Rivian Shares Drop 4.4% With $1.1 Billion Wiped Out as CFO Departure Raises Questions for R2 Launch

Investment Disclaimer